{"id":"NCT02636699","sponsor":"DBV Technologies","briefTitle":"Efficacy and Safety of Viaskin Peanut in Children With Immunoglobulin E (IgE)-Mediated Peanut Allergy","officialTitle":"A Double-blind, Placebo-controlled, Randomized Phase 3 Pivotal Trial to Assess the Efficacy and Safety of Peanut Epicutaneous Immunotherapy With Viaskin Peanut in Peanut-allergic Children","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2015-12","primaryCompletion":"2017-08-18","completion":"2017-08-18","firstPosted":"2015-12-22","resultsPosted":"2021-10-15","lastUpdate":"2025-06-18"},"enrollment":500,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"TRIPLE","primaryPurpose":"TREATMENT"},"conditions":["Peanut Allergy"],"interventions":[{"type":"BIOLOGICAL","name":"Viaskin Peanut 250mcg","otherNames":["DBV712"]},{"type":"BIOLOGICAL","name":"Placebo","otherNames":[]}],"arms":[{"label":"Viaskin Peanut 250mcg","type":"EXPERIMENTAL"},{"label":"Placebo","type":"PLACEBO_COMPARATOR"}],"summary":"The PEPITES study evaluates the efficacy and safety of Viaskin Peanut 250 µg peanut protein to induce desensitization to peanut in peanut-allergic children 4 through 11 years of age after a 12-month treatment by epicutaneous immunotherapy (EPIT).","primaryOutcome":{"measure":"Difference in Percentages of Treatment Responders at Month 12; Analyzed in the Overall Population","timeFrame":"At Month 12","effectByArm":[{"arm":"DBV712 250 μg","deltaMin":35.3,"sd":null},{"arm":"Placebo","deltaMin":13.6,"sd":null}],"pValues":[{"comp":"OG000 vs OG001","p":"<0.001"}]},"eligibility":{"minAge":"4 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":null,"exclusionCount":null},"locations":{"siteCount":31,"countries":["United States","Australia","Canada","Germany","Ireland"]},"refs":{"pmids":["30794314","32502548","33259921","31442495"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":10,"n":238},"commonTop":["Upper respiratory tract infection","Application site pruritus","Application site erythema","Pyrexia","Viral upper respiratory tract infection"]}}